Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.73 |
| ▸ | TSHR | P16473 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | GLA | P06280 | 1/20 | 0.60 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.58 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.58 |
| ▸ | KDM1A | O60341 | 1/20 | 0.57 |
| ▸ | FOS | P01100 | 1/20 | 0.56 |
| ▸ | TTR | P02766 | 1/20 | 0.56 |
| ▸ | JUN | P05412 | 1/20 | 0.56 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.56 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.56 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1033641 | 0.87 | LMNA (0.61) | GAAALDH1A1MAPK1LMNAGLA | |
| SCHEMBL29602721 | 0.87 | LMNA (0.61) | GAAALDH1A1MAPK1LMNAGLA | |
| SCHEMBL5724393 | 0.86 | GAA (0.73) | GAATSHRALDH1A1NFKB1TDP1 | |
| SCHEMBL7114863 | 0.86 | TSHR (0.77) | GAATSHRALDH1A1NFKB1TDP1 | |
| SCHEMBL19545803 | 0.85 | GAA (0.71) | GAATSHRALDH1A1NFKB1TDP1 | |
| Homovanillic Acid SCHEMBL8792 | 0.84 | GAA (1.00) | GAATSHRALDH1A1NFKB1TDP1 | |
| SCHEMBL1682653 | 0.84 | TSHR (0.75) | GAATSHRALDH1A1NFKB1TDP1 | |
| SCHEMBL30310281 | 0.84 | TSHR (0.75) | GAATSHRALDH1A1NFKB1TDP1 | |
| SCHEMBL30310280 | 0.84 | TSHR (0.75) | GAATSHRALDH1A1NFKB1TDP1 | |
| Homovanillic Acid SCHEMBL10535396 | 0.84 | GAA (1.00) | GAATSHRALDH1A1NFKB1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8329948-B2 | Method for the synthesis of substituted formylamines and substituted amines | BOBYLEV MIKHAIL (US) | 2012-12-11 | — | — | US | claimed |
| EP-1517880-B1 | PRODUCTION OF CIS-PELLITORIN AND USE AS A FLAVOURING | SYMRISE AG (DE) | 2011-01-05 | — | — | EP | claimed |
| EP-2175854-A1 | IMPROVED METHOD FOR THE SYNTHESIS OF SUBSTITUTED FORMYLAMINES AND SUBSTITUTED AMINES | University Of North Dakota Research Foundation (US) | 2010-04-21 | — | — | EP | claimed |
| US-20090143622-A1 | Method For The Synthesis Of Substituted Formylamines And Substituted Amines | BOBYLEV MIKHAIL | 2009-06-04 | — | — | US | claimed |
| WO-2009018353-A1 | IMPROVED METHOD FOR THE SYNTHESIS OF SUBSTITUTED FORMYLAMINES AND SUBSTITUTED AMINES | UNIVERSITY OF NORTH DAKOTA RESEARCH FOUNDATION (US) | 2009-02-05 | — | — | WO | claimed |
| EP-1633348-B1 | 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | ELAN PHARM INC (US) | 2008-10-08 | — | — | EP | claimed |
| US-20050020659-A1 | Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | ELAN PHARMACEUTICALS, INC. | 2005-01-27 | — | — | US | claimed |
| US-20030191069-A1 | 2-oxoquinoline compounds and pharmaceutical uses thereof | JAPAN TOBACCO, INC (JP) | 2003-10-09 | — | — | US | claimed |
| US-6509352-B1 | Selectively act on cannabinoid receptors, particularly on peripheral type cannabinoid receptors, and have fewer side effects on the central nervous system, having great immunosuppressive action, anti-inflammatory action or | JAPAN TOBACCO INC. (JP) | 2003-01-21 | — | — | US | claimed |
| EP-1142877-A1 | 2-OXOQUINOLINE COMPOUNDS AND MEDICINAL USES THEREOF | JAPAN TOBACCO INC. (JP) | 2001-10-10 | — | — | EP | claimed |
| US-12030326-B2 | System and method for printing and drying flavors and fragrances | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240180220-A1 | HYDROGEL ENCAPSULATIONS AND METHODS OF MAKING THE SAME | INTERNATIONAL FLAVORS & FRANGRANCES INC. | 2024-06-06 | — | — | US | disclosed |
| WO-2024100137-A1 | CELL COMPOSITIONS | GIVAUDAN SA (CH) | 2024-05-16 | — | — | WO | disclosed |
| US-11950607-B2 | Myceliated vegetable protein and food compositions comprising same | Mycotechnology, Inc. (US) | 2024-04-09 | — | — | US | disclosed |
| US-11937622-B2 | Obtaining a volatile fraction from juices or alcoholic beverages | SYMRISE AG (DE) | 2024-03-26 | — | — | US | disclosed |
| EP-0874805-A1 | PHENYLACETAMIDE DERIVATIVES | Korea Research Institute of Chemical Technology (KR) | 1998-11-04 | — | — | EP | disclosed |
| WO-1997021668-A1 | PHENYLACETAMIDE DERIVATIVES | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 1997-06-19 | — | — | WO | disclosed |
| EP-0089710-B1 | NOVEL HYDROXYPHENYLACETAMIDES HAVING ANALGESIC AND ANTI-IRRITANT ACTIVITY | THE PROCTER & GAMBLE COMPANY (US) | 1985-07-31 | — | — | EP | disclosed |
| US-4424205-A | DEPILLATORIES | THE PROCTER & GAMBLE COMPANY (US) | 1984-01-03 | — | — | US | disclosed |
| EP-0089710-A1 | Novel hydroxyphenylacetamides having analgesic and anti-irritant activity | THE PROCTER & GAMBLE COMPANY (US) | 1983-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020659-A1 | Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | BDKRB1, BDKRB2, BRS3 | GAA 4207/4885TSHR 898/4885ALDH1A1 3054/4885 |
| US-20030191069-A1 | 2-oxoquinoline compounds and pharmaceutical uses thereof | CNR2, CNR1, OPRL1 | GAA 4692/4885TSHR 2580/4885ALDH1A1 2343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.